|
|
Office Locations:
|
525 University Avenue, Suite 800
Palo Alto, CA 94301-1922
Phone: 650-321-8000
| |
|
|
|
|
Business Services
Communications & Networking
Consumer Products & Services
Information Technology
Life Sciences & Healthcare
Software & Internet
|
|
|
Founded in 1961, Norwest Venture Partners (NVP) manages nearly $9.5 billion in venture capital and has funded over 600 companies. The firm provides capital to seed-stage and early-stage companies with a general goal to invest between $10 million and $15 million in its companies over time. Norwest sometimes begins with a smaller amount (as little as $1 million to $5 million), and may invest as much as $25 to $30 million. For growth equity companies, NVP aims to invest between $20 million and $150 million in fast growing companies with strong market positions, significant revenue and net income traction. NVP invests in both listed and unlisted companies. The investment focus of Norwest Venture Partners is technology (cloud & IT infrastructure, Internet & consumer, SaaS), business services, financial services, consumer products/services, and healthcare. In May of 2014, the firm announced the formation of its latest fund, Norwest Venture Partners XII, LP with $1.2B.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|
|
Name | |
| |
Title | |
|
Casper De Clercq | |
| |
General Partner | |
Dr. Ryan A. Harris | |
| |
General Partner | |
Dror Nahumi | |
| |
General Partner | |
Elaine Dai | |
| |
Associate | |
Jeffrey Crowe | |
| |
Managing Partner | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
12/06/2024
|
Nuvig Therapeutics
|
CA
|
$161,000,000
|
Series B
|
10/30/2024
|
Third Wave Automation
|
CA
|
$27,000,000
|
Series C
|
10/10/2024
|
CytoVale
|
CA
|
$100,000,000
|
Series D
|
10/09/2024
|
ShiraTronics
|
MO
|
$66,000,000
|
Series B
|
10/01/2024
|
Xtype
|
CA
|
$21,000,000
|
Series A
|
09/17/2024
|
Intezer
|
NY
|
$33,000,000
|
Series C
|
07/22/2024
|
Heeler Security
|
MD
|
$8,500,000
|
Seed
|
07/09/2024
|
Courier Health
|
NY
|
$16,500,000
|
Series A
|
06/12/2024
|
Learn to Win
|
CA
|
$30,000,000
|
Series A
|
05/07/2024
|
Legion Technologies
|
CA
|
$50,000,000
|
Growth
|
04/02/2024
|
Lumana
|
CA
|
$24,000,000
|
Seed
|
03/21/2024
|
Ediphi
|
CA
|
$12,000,000
|
Series A
|
03/19/2024
|
Engrail Therapeutics
|
CA
|
$157,000,000
|
Series B
|
|
|
|
|
|